Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1865 2
1866 1
1867 1
1868 1
1880 1
1904 1
1915 1
1920 1
1923 1
1925 1
1927 2
1929 1
1931 1
1934 1
1946 1
1947 3
1948 1
1955 1
1956 1
1958 2
1959 4
1960 5
1961 4
1962 1
1963 4
1964 2
1965 1
1967 3
1968 4
1969 1
1970 2
1971 3
1972 2
1973 3
1974 3
1976 1
1977 1
1979 1
1980 2
1981 1
1982 4
1984 2
1986 6
1987 4
1988 5
1989 6
1990 11
1991 10
1992 8
1993 11
1994 17
1995 11
1996 17
1997 14
1998 21
1999 28
2000 20
2001 20
2002 21
2003 17
2004 18
2005 19
2006 21
2007 40
2008 33
2009 48
2010 53
2011 40
2012 32
2013 49
2014 55
2015 56
2016 68
2017 66
2018 75
2019 69
2020 77
2021 100
2022 82
2023 65
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

1,293 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of mast cell activation syndrome: a global "consensus-2".
Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, Cuni JR, Davey WP, Dempsey TT, Dorff SR, Dubravec MS, Guggenheim AG, Hindman KJ, Hoffman B, Kaufman DL, Kratzer SJ, Lee TM, Marantz MS, Maxwell AJ, McCann KK, McKee DL, Menk Otto L, Pace LA, Perkins DD, Radovsky L, Raleigh MS, Rapaport SA, Reinhold EJ, Renneker ML, Robinson WA, Roland AM, Rosenbloom ES, Rowe PC, Ruhoy IS, Saperstein DS, Schlosser DA, Schofield JR, Settle JE, Weinstock LB, Wengenroth M, Westaway M, Xi SC, Molderings GJ. Afrin LB, et al. Among authors: maxwell aj. Diagnosis (Berl). 2020 Apr 22;8(2):137-152. doi: 10.1515/dx-2020-0005. Print 2021 May 26. Diagnosis (Berl). 2020. PMID: 32324159 Free article. Review.
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.
Pilette C, Canonica GW, Chaudhuri R, Chupp G, Lee FE, Lee JK, Almonacid C, Welte T, Alfonso-Cristancho R, Jakes RW, Maxwell A, Price RG, Howarth P. Pilette C, et al. Among authors: maxwell a. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2646-2656. doi: 10.1016/j.jaip.2022.05.042. Epub 2022 Jun 24. J Allergy Clin Immunol Pract. 2022. PMID: 35753668 Free article.
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis.
Harrison T, Canonica GW, Chupp G, Lee J, Schleich F, Welte T, Valero A, Gemzoe K, Maxwell A, Joksaite S, Yang S, Howarth P, Van Dyke MK. Harrison T, et al. Among authors: maxwell a. Eur Respir J. 2020 Oct 15;56(4):2000151. doi: 10.1183/13993003.00151-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32817259 Free PMC article.
An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism.
Lees JA, Dias JM, Rajamohan F, Fortin JP, O'Connor R, Kong JX, Hughes EAG, Fisher EL, Tuttle JB, Lovett G, Kormos BL, Unwalla RJ, Zhang L, Dechert Schmitt AM, Zhou D, Moran M, Stevens KA, Fennell KF, Varghese AE, Maxwell A, Cote EE, Zhang Y, Han S. Lees JA, et al. Among authors: maxwell a. Nat Commun. 2023 Sep 23;14(1):5938. doi: 10.1038/s41467-023-41646-3. Nat Commun. 2023. PMID: 37741852 Free PMC article.
Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis.
Liu MC, Bagnasco D, Matucci A, Pilette C, Price RG, Maxwell AC, Alfonso-Cristancho R, Jakes RW, Lee JK, Howarth P. Liu MC, et al. Among authors: maxwell ac. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3650-3661.e3. doi: 10.1016/j.jaip.2023.07.024. Epub 2023 Jul 26. J Allergy Clin Immunol Pract. 2023. PMID: 37507070 Free article.
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.
Sandholm N, Cole JB, Nair V, Sheng X, Liu H, Ahlqvist E, van Zuydam N, Dahlström EH, Fermin D, Smyth LJ, Salem RM, Forsblom C, Valo E, Harjutsalo V, Brennan EP, McKay GJ, Andrews D, Doyle R, Looker HC, Nelson RG, Palmer C, McKnight AJ, Godson C, Maxwell AP, Groop L, McCarthy MI, Kretzler M, Susztak K, Hirschhorn JN, Florez JC, Groop PH; GENIE Consortium. Sandholm N, et al. Among authors: maxwell ap. Diabetologia. 2022 Sep;65(9):1495-1509. doi: 10.1007/s00125-022-05735-0. Epub 2022 Jun 28. Diabetologia. 2022. PMID: 35763030 Free PMC article.
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F, Rubis N, Peracchi T, Villa A, Todeschini M, Carrara F, Magee BA, Ruggenenti PL, Rota S, Cappelletti L, McInerney V, Griffin TP, Islam MN, Introna M, Pedrini O, Golay J, Finnerty AA, Smythe J, Fibbe WE, Elliman SJ, O'Brien T; NEPHSTROM Trial Consortium. Perico N, et al. Among authors: maxwell ap. J Am Soc Nephrol. 2023 Oct 1;34(10):1733-1751. doi: 10.1681/ASN.0000000000000189. Epub 2023 Aug 10. J Am Soc Nephrol. 2023. PMID: 37560967 Clinical Trial.
1,293 results